Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTSV (Clinical Trial Support for Vaccine) is a South Korean biotechnology company and specialized contract research organization (CRO) dedicated to vaccine development and clinical trial management. Established in 2020, the company provides comprehensive services including clinical trial design, regulatory consulting, and monitoring specifically for vaccine candidates. Beyond its CRO services, CTSV actively participates in the research and development of its own vaccine pipeline, focusing on infectious diseases such as COVID-19. The organization serves as a critical bridge between laboratory research and commercial vaccine production within the Asian biopharmaceutical market. It maintains strong ties with international health organizations to accelerate the global distribution of preventive medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinical Trial Support for Vaccine.